FTH (Faeth Therapeutics) Other Current Liabilities: $4.31 Mil (As of Mar. 2026)


FTH Faeth Therapeutics Inc FTH
21 GF Score
Price $24.96
! 2 Warning Signs
View Full Analysis

What is Faeth Therapeutics Other Current Liabilities?

Faeth Therapeutics FTH +0.70% 21 Other Current Liabilities is $4.31 Mil as of Mar. 2026. GuruFocus rates FTH with a GF Score™ of 21/100. The stock has 2 warning signs investors should review.

Faeth Therapeutics's other current liabilities for the quarter that ended in Mar. 2026 was $4.31 Mil.

Faeth Therapeutics's quarterly other current liabilities increased from Sep. 2025 ($1.24 Mil) to Dec. 2025 ($1.40 Mil) and increased from Dec. 2025 ($1.40 Mil) to Mar. 2026 ($4.31 Mil).

Faeth Therapeutics's annual other current liabilities increased from Dec. 2023 ($1.51 Mil) to Dec. 2024 ($2.01 Mil) but then declined from Dec. 2024 ($2.01 Mil) to Dec. 2025 ($1.40 Mil).

Faeth Therapeutics Other Current Liabilities Related Terms

Faeth Therapeutics Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Faeth Therapeutics's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Faeth Therapeutics Other Current Liabilities Chart

Faeth Therapeutics Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial 1.75 2.46 1.51 2.01 1.40

Faeth Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.80 0.85 1.24 1.40 4.31
FTH
21GF Score
Faeth Therapeutics Inc FTH
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Faeth Therapeutics Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $4.31 Mil mean?
Faeth Therapeutics (FTH) has a Other Current Liabilities of $4.31 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Faeth Therapeutics.
Is Faeth Therapeutics' Other Current Liabilities too high?
Faeth Therapeutics' current Other Current Liabilities is $4.31 Mil. Overall, Faeth Therapeutics has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Faeth Therapeutics' Other Current Liabilities compare to NEUP and KYNB?
Faeth Therapeutics' Other Current Liabilities of $4.31 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Faeth Therapeutics. Faeth Therapeutics's current Other Current Liabilities is $4.31 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Faeth Therapeutics stock overvalued right now?
Faeth Therapeutics (FTH) has a current Other Current Liabilities of $4.31 Mil. The current Other Current Liabilities is $4.31 Mil. Faeth Therapeutics' overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Faeth Therapeutics (FTH), the current Other Current Liabilities is $4.31 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Faeth Therapeutics Business Description

Address 701 Tillery Street No. 12, No.1010, Austin, TX, USA, 78702
Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.
21GF Score

Get the complete analysis for FTH

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$24.96
Price